Literature DB >> 28239916

Epidemiology of rosacea in Colombia.

Lili J Rueda1, Adriana Motta1, Juan G Pabón2, Maria I Barona3, Esperanza Meléndez4, Beatriz Orozco5, Ricardo F Rojas6.   

Abstract

BACKGROUND: Prevalence of rosacea has been estimated around the world in the range of 0-22%. In Colombia, the prevalence of rosacea remains unknown. The aim of this study was to determine the prevalence of rosacea and the frequencies of its subtypes in Colombia.
METHODS: This cross-sectional, multicenter study was conducted in six outpatient dermatology clinics across Colombia. A total of 33 dermatologists conducted a comprehensive medical history and physical examination for all rosacea patients seen at their offices over the course of 2 months. All patients who accepted to participate were encouraged to answer a survey about the history of their illness.
RESULTS: Of 10,204 outpatients evaluated for rosacea between July and August 2014, 291 rosacea patients were included in this study. The prevalence of rosacea subtypes in this cohort was: 45.3% erythematotelangiectatic (ETR) (n = 132), 48.7% papulopustular (PPR) (n = 142), 4.8% phymatous (n = 14), and 1% ocular (n = 3).
CONCLUSIONS: Overall, the prevalence in Colombia was 2.85%. Our data represent an important first step to understanding the current state of rosacea in Colombia. The prevalence of rosacea in Colombia is the highest in Latin America among a few reports published, which might be explained by geographic features. However, contrary to our expectations, the prevalence is lower than that in some European countries. We postulate that this finding may be due to methodological differences.
© 2017 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2017        PMID: 28239916     DOI: 10.1111/ijd.13491

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.

Authors:  Athanasios Tsianakas; Thomas Pieber; Hilary Baldwin; Franz Feichtner; Shanavas Alikunju; Anirudh Gautam; Srinivas Shenoy; Preeti Singh; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2021-12

Review 2.  Dermatology: how to manage rosacea in skin of colour.

Authors:  Khalad Maliyar; Sonya J Abdulla
Journal:  Drugs Context       Date:  2022-05-31

3.  The Risk of Rosacea According to Chronic Diseases and Medications: A 5-Year Retrospective, Multi-Institutional Case-Control Study.

Authors:  Jee Hee Son; Bo Young Chung; Min Je Jung; Yong Won Choi; Hye One Kim; Chun Wook Park
Journal:  Ann Dermatol       Date:  2018-10-26       Impact factor: 1.444

Review 4.  Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies.

Authors:  Mark C Marchitto; Anna L Chien
Journal:  Dermatol Ther (Heidelb)       Date:  2021-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.